Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Noble Acquires Property with Significant Uranium, Rare Ear nobleth, Phosphorus & Silver (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Collegium Pharmaceutical Inc COLL

Healthcare Biotechnology
Collegium Pharmaceutical, Inc. is a diversified specialty pharmaceutical company. The Company commercializes its pain portfolio, consisting of Xtampza extended-release (ER), Nucynta ER and Nucynta immediate-release (IR), Belbuca, and Symproic in the United States. Xtampza ER is an abuse-deterrent, extended-release, oral formulation of oxycodone. Xtampza ER is a pain treatment option designed... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:COLL)

Collegium Provides 2025 Financial Guidance and Business Update

GlobeNewswire 9 days ago

Collegium to Participate in Upcoming Investor Conferences

GlobeNewswire November 12, 2024

Collegium Reports Record Third Quarter 2024 Financial Results

GlobeNewswire November 7, 2024

Collegium Appoints Vikram Karnani as Chief Executive Officer

GlobeNewswire November 7, 2024

Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024

GlobeNewswire October 24, 2024

Collegium Completes Acquisition of Ironshore Therapeutics

GlobeNewswire September 4, 2024

Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire August 30, 2024

Collegium Announces Eight Poster Presentations at PAINWeek Conference 2024

GlobeNewswire August 28, 2024

Collegium Reports Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024
View More News ››

Opinion & Analysis (NDAQ:COLL)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:COLL)

When the Price of (COLL) Talks, People Listen

Just In: $COLL When the Price of (COLL) Talks, People Listen2024-09-18 11:40:00 ET Stock Traders Daily has produced this trading report...
whytestocks - September 18, 2024

Buy Recommendation Issued On COLL By Jefferies

JUST IN: $COLL Buy Recommendation Issued On COLL By Jefferies2024-06-07 06:30:03 ET Jefferies analyst issues BUY recommendation for COLL...
whytestocks - June 7, 2024
View more Bullboard ››

Mullen Group Ltd.

Mullen Group Ltd.

Mullen Group is one of North America's largest logistics providers with a network of independently operated businesses ...
View More »